Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients

NCT07430683 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

DRUG: Valganciclovir Prophylaxis
DIAGNOSTIC_TEST: Preemptive Therapy (CMV PCR Monitoring)

Sponsor

University of Guadalajara

Collaborators

[object Object]